307353-32-8

Basic information

• Product Name: METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE
• Synonyms: METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE;3-Bromo-5-hydroxymethyl-benzoic acid methyl ester
• CAS NO: 307353-32-8
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.08
• Mol File: 307353-32-8.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 354.2±32.0 °C(Predicted)
• Appearance: /
• Density: 1.557±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.08±0.10(Predicted)
• CAS DataBase Reference: METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE(307353-32-8)
• EPA Substance Registry System: METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE(307353-32-8)

Safety Data

• Hazardous Substances Data: 307353-32-8(Hazardous Substances Data)

Usage

General Description

Methyl 3-bromo-5-(hydroxymethyl)benzoate is a chemical compound with the molecular formula C9H9BrO3. It is a derivative of benzoic acid and belongs to the class of organic compounds known as benzoates. METHYL 3-BROMO-5-(HYDROXYMETHYL)BENZOATE is typically used in the synthesis of pharmaceuticals and agrochemicals due to its versatile chemical properties. It is known for its ability to act as a building block in the production of various drugs and compounds, making it an important intermediate in organic chemistry research and pharmaceutical development. Additionally, its unique chemical structure and reactivity make it an important target for further study and manipulation in the field of chemical synthesis.

Upstream product

• 51760-21-5 dimethyl 5-bromoisophthalate 
• 161796-10-7 3-bromo-5-(methoxycarbonyl)benzoic acid 
• 220286-47-5 3-Amino-5-hydroxymethylbenzoic acid methyl ester 

Downstream Products

• 877624-40-3 methyl 3-bromo-5-(bromomethyl)benzoate 
• 225657-76-1 3-(3-cyanophenyl)-5-(hydroxymethyl)benzoic acid methyl ester 
• 1186517-97-4 3-(2-(diethylamino)-1-hydroxyethyl)-5-(5-methylpyridin-2-yl)-N-((R)-1-(6-methylpyridin-3-yl)ethyl)benzamide 
• 1186517-31-6 5-(hydroxy(thiazol-2-yl)methyl)-4'-methyl-N-((R)-1-(6-methylpyridin-3-yl)ethyl)biphenyl-3-carboxamide 
• 1186520-10-4 3-(2-(diethylamino)-2-hydroxyethyl)-5-(5-methylpyridin-2-yl)benzoic acid 
• 1186519-36-7 methyl 3-(2-(diethylamino)-2-hydroxyethyl)-5-(5-methylpyridin-2-yl)benzoate 
• 1186519-22-1 5-(hydroxy(thiazol-2-yl)methyl)-4'-methylbiphenyl-3-carboxylic acid 
• 1186519-92-5 methyl 5-(hydroxy(thiazol-2-yl)methyl)-4'-methylbiphenyl-3-carboxylate 
• 1186519-35-6 methyl 3-bromo-5-(1-(diethylamino)-2-hydroxyethyl)benzoate 
• 1186519-94-7 methyl 3-bromo-5-(2,2,2-trifluoro-1-hydroxyethyl)benzoate 
• 1186519-21-0 methyl 3-bromo-5-(hydroxy(thiazol-2-yl)methyl)benzoate 
• 1186519-97-0 methyl 3-bromo-5-(1,2-dihydroxyethyl)benzoate 
• 1186520-08-0 methyl 3-bromo-5-((dimethylamino)methyl)benzoate 
• 1186519-34-5 methyl 3-bromo-5-(oxiran-2-yl)benzoate 

Relevant articles and documents

Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors

The ubiquitin–proteasome system (UPS) plays an important role in maintaining protein homeostasis by degrading intracellular proteins. In the proteasome, poly-ubiquitinated proteins are deubiquitinated by three deubiquitinases (DUBs) associated with 19S re

Discovery of a potent class of PI3Kα inhibitors with unique binding mode via encoded library technology (ELT4)

In the search of PI3K p110α wild type and H1047R mutant selective small molecule leads, an encoded library technology (ELT) campaign against the desired target proteins was performed which led to the discovery of a selective chemotype for PI3K isoforms from a three-cycle DNA encoded library. An X-ray crystal structure of a representative inhibitor from this chemotype demonstrated a unique binding mode in the p110α protein.

AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF

Compounds are provided according to formula (1 ) : where A, B, W, X', L, R1, R3, R4b, and m' are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.